下肢血运重建治疗静息痛与组织缺损的围术期结局
基于美国外科医师学会国家手术质量改进计划2012至2016年数据库,纳入5304例因严重肢体缺血行股-腘动脉旁路术的患者,按ICD编码分为静息痛(RP)与组织缺损(TL)两组。TL组合并症更多、病情更重,30天并发症、死亡、大截肢和再入院率均显著高于RP组,TL是30天并发症与大截肢的独立预测因素。
要点
- 组织缺损患者30天并发症、死亡、大截肢和再入院风险均显著高于静息痛患者
- 组织缺损是30天并发症(OR 1.16)和大截肢(OR 2.48)的独立预测因素
- 建议将严重肢体缺血分层为静息痛与组织缺损以量化手术风险
核心结论
- 静息痛与组织缺损患者存在显著差异,影响围术期死亡率和再入院。
- 组织缺损是30天并发症和大截肢的独立预测因素。
- 将严重肢体缺血分层为静息痛与组织缺损有助于理解结局差异并量化风险。
研究设计与样本
- 回顾性数据库研究,数据来自美国外科医师学会国家手术质量改进计划2012至2016年数据库。
- 纳入所有术后诊断为严重肢体缺血并接受股-腘动脉旁路术(静脉或移植物)的患者,共5304例。
- 按ICD-9或ICD-10编码将患者分为静息痛组与组织缺损(坏疽或溃疡)组。
- 采用单因素和多因素分析,校正人口学、合并症和手术细节后评估30天死亡率、并发症、大截肢和再入院。
主要发现
- 组织缺损患者较静息痛患者年龄更大(P < 0.0001)且更可能依赖他人(P < 0.0001)。
- 组织缺损患者更常合并糖尿病(P < 0.0001)、充血性心力衰竭(P < 0.0001)、肾衰竭(P = 0.004)、透析(P < 0.0001)、伤口感染史(P < 0.0001)和脓毒症(P < 0.0001)。
- 组织缺损患者ASA分级更高(P < 0.0001),更少来自家庭(P < 0.0001),更常接受静脉旁路术(P = 0.03)。
- 组织缺损患者肺炎(P = 0.004)、非计划插管(P = 0.009)、需心肺复苏的心脏骤停(P = 0.003)、需输血出血(P < 0.0001)、脓毒症(P < 0.0001)、脓毒性休克(P = 0.02)和再手术(P < 0.0001)发生率更高。
- 组织缺损与更高的30天并发症(P < 0.0001)、30天死亡率(P < 0.0001)、大截肢(P = 0.0004)和再入院率(P = 0.005)相关,住院时间及术后至出院天数也更长(P < 0.0001)。
关键数值与推荐
- 组织缺损与30天并发症增加独立相关(OR:1.16 [1.00-1.35])。
- 组织缺损与大截肢增加独立相关(OR:2.48 [1.29-4.76])。
临床怎么用
- 对严重肢体缺血患者应区分静息痛与组织缺损进行风险分层。
- 组织缺损患者围术期应加强并发症防控、截肢风险评估和出院规划。
- 向患者及家属交代预后时需考虑组织缺损带来的更高死亡、截肢和再入院风险。
局限性
- 为回顾性数据库研究,可能存在编码偏倚和未测量混杂。
- 仅纳入接受股-腘动脉旁路术的患者,结论外推至其他血运重建方式需谨慎。
- 随访仅限30天围术期结局,缺乏长期结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Critical limb ischemia (CLI) is the clinical manifestation of severe peripheral artery disease presenting as rest pain (RP) and tissue loss (TL). Most studies compare CLI as a homogenous group with claudication with limited database studies specifically studying these differences. We hypothesize that CLI should be stratified into RP and TL because of significant differences in disease severity, comorbidities, and outcomes. METHODS: The American College of Surgeons National Surgical Quality Improvement Program database from 2012 to 2016 was reviewed. All patients with a postoperative diagnosis of CLI undergoing femoral to popliteal bypass (FPB) with vein or graft were identified. Patients were stratified into cohorts based on International Classification of Disease (ICD)-9 or ICD-10 codes for RP or TL (gangrene or ulcer). Univariate and multivariate analyses were performed to examine 30-day mortality, morbidity, major amputation, and readmission adjusting for demographics, comorbidities, and procedural details. RESULTS: There were 5,304 patients. Compared to RP, patients with TL were older (P < 0.0001) and more likely to be dependent (P < 0.0001). TL patients were also more likely to have diabetes (P < 0.0001), congestive heart failure (P < 0.0001), renal failure (P = 0.004), dialysis (P < 0.0001), history of wound infection (P < 0.0001), and sepsis (P < 0.0001). TL patients had higher American Society of Anesthesiologists class (P < 0.0001), were less likely to be transferred from home (P < 0.0001), and more likely to receive an FPB with vein (P = 0.03). Patients with TL had worse perioperative outcomes compared with RP in terms of pneumonia (P = 0.004), unplanned intubation (P = 0.009), cardiac arrest requiring cardiopulmonary resuscitation (P = 0.003), bleeding requiring transfusions (P < 0.0001), sepsis (P < 0.0001), septic shock (P = 0.02), and reoperation (P < 0.0001). TL was associated with significantly higher 30-day morbidity (P < 0.0001), 30-day mortality (P < 0.0001), major amputation (P = 0.0004), and readmission rates (P = 0.005). Patients with TL compared with those with RP also had longer hospital stays (P < 0.0001) and days between operation to discharge (P < 0.0001). TL was independently associated with increased 30-day morbidity (OR: 1.16 [1.00-1.35]) and major amputation (OR: 2.48 [1.29-4.76]) compared with RP. CONCLUSIONS: Patients with RP and TL have drastic differences that impact perioperative mortality and readmissions. TL is an independent predictor of 30-day morbidity and major amputation. The stratification of CLI into RP and TL can provide insight into variations in outcomes and provide a means to quantify the risks associated with the 2 manifestations of the disease.
引用
- Tsay C, Luo J, Zhang Y, et al. Perioperative Outcomes of Lower Extremity Revascularization for Rest Pain and Tissue Loss. Ann Vasc Surg. 2019. PMID: 31756416. doi:10.1016/j.avsg.2019.11.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。